These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32885593)

  • 1. SATB2 is a novel biomarker and therapeutic target for cancer.
    Roy SK; Shrivastava A; Srivastav S; Shankar S; Srivastava RK
    J Cell Mol Med; 2020 Oct; 24(19):11064-11069. PubMed ID: 32885593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SATB2/β-catenin/TCF-LEF pathway induces cellular transformation by generating cancer stem cells in colorectal cancer.
    Yu W; Ma Y; Shankar S; Srivastava RK
    Sci Rep; 2017 Sep; 7(1):10939. PubMed ID: 28887549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic Role of SATB2 In Vitro: Regulator of Pluripotency, Self-Renewal, and Epithelial-Mesenchymal Transition in Prostate Cancer.
    Yu W; Srivastava R; Srivastava S; Ma Y; Shankar S; Srivastava RK
    Cells; 2024 Jun; 13(11):. PubMed ID: 38891096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of SATB2 in human pancreatic cancer: Implications in transformation and a promising biomarker.
    Yu W; Ma Y; Shankar S; Srivastava RK
    Oncotarget; 2016 Sep; 7(36):57783-57797. PubMed ID: 27472393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher expression of SATB2 in hepatocellular carcinoma of African Americans determines more aggressive phenotypes than those of Caucasian Americans.
    Yu W; Roy SK; Ma Y; LaVeist TA; Shankar S; Srivastava RK
    J Cell Mol Med; 2019 Dec; 23(12):7999-8009. PubMed ID: 31602781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
    Li Y; Liu YH; Hu YY; Chen L; Li JM
    World J Gastroenterol; 2016 Oct; 22(38):8528-8539. PubMed ID: 27784965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic alcohol exposure induces hepatocyte damage by inducing oxidative stress, SATB2 and stem cell-like characteristics, and activating lipogenesis.
    Yu W; Ma Y; Shrivastava SK; Srivastava RK; Shankar S
    J Cell Mol Med; 2022 Apr; 26(7):2119-2131. PubMed ID: 35152538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics.
    Tang SN; Fu J; Nall D; Rodova M; Shankar S; Srivastava RK
    Int J Cancer; 2012 Jul; 131(1):30-40. PubMed ID: 21796625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular transformation of human mammary epithelial cells by SATB2.
    Yu W; Ma Y; Ochoa AC; Shankar S; Srivastava RK
    Stem Cell Res; 2017 Mar; 19():139-147. PubMed ID: 28167342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of C-terminal binding protein attenuates transcription factor 4 signaling to selectively target colon cancer stem cells.
    Patel J; Baranwal S; Love IM; Patel NJ; Grossman SR; Patel BB
    Cell Cycle; 2014; 13(22):3506-18. PubMed ID: 25483087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of SATB2 is critical for induction of epithelial-to-mesenchymal transition and invasion of NSCLC cells.
    Kucuksayan H; Ozes ON; Akca H
    Lung Cancer; 2016 Aug; 98():122-129. PubMed ID: 27393518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sanguinarine inhibits pancreatic cancer stem cell characteristics by inducing oxidative stress and suppressing sonic hedgehog-Gli-Nanog pathway.
    Ma Y; Yu W; Shrivastava A; Alemi F; Lankachandra K; Srivastava RK; Shankar S
    Carcinogenesis; 2017 Oct; 38(10):1047-1056. PubMed ID: 28968696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog.
    Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S
    J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
    PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients.
    Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition.
    Shankar S; Nall D; Tang SN; Meeker D; Passarini J; Sharma J; Srivastava RK
    PLoS One; 2011 Jan; 6(1):e16530. PubMed ID: 21304978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.
    Gavert N; Vivanti A; Hazin J; Brabletz T; Ben-Ze'ev A
    Mol Cancer Res; 2011 Jan; 9(1):14-24. PubMed ID: 21123622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4
    Liu L; Zhu H; Liao Y; Wu W; Liu L; Liu L; Wu Y; Sun F; Lin HW
    Biomed Pharmacother; 2020 Jul; 127():110225. PubMed ID: 32428834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Mangostin-encapsulated PLGA nanoparticles inhibit colorectal cancer growth by inhibiting Notch pathway.
    Chandra Boinpelly V; Verma RK; Srivastav S; Srivastava RK; Shankar S
    J Cell Mol Med; 2020 Oct; 24(19):11343-11354. PubMed ID: 32830433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.